Authors: Hughes, ODM Perkins, AC Frier, M Wastie, ML Denton, G Price, MR Denley, H Bishop, MC

Citation: Odm. Hughes et al., Imaging for staging bladder cancer: a clinical study of (111)indium-labelled anti-MUC1 mucin intravenous monoclonal antibody C595, BJU INT, 87(1), 2001, pp. 39-46

Authors: Smith, SL Vincent, RM Perkins, AC Wastie, ML Sokal, M

Citation: Sl. Smith et al., Does simple estimation of I-131-meta-iodobenzylguanidine uptake in patients with neural crest tumours correlate with clinical outcome?, NUCL MED C, 22(2), 2001, pp. 257-260

Authors: Smith, SL Wastie, ML Forster, I

Citation: Sl. Smith et al., Radionuclide bone scintigraphy in the detection of significant complications after total knee joint replacement, CLIN RADIOL, 56(3), 2001, pp. 221-224

Authors: Hughes, ODM Bishop, MC Perkins, AC Wastie, ML Denton, G Price, MR Frier, M Denley, H Rutherford, R Schubiger, PA

Citation: Odm. Hughes et al., Targeting superficial bladder cancer by the intravesical administration ofcopper-67-labeled anti-MUC1 mucin monoclonal antibody C595, J CL ONCOL, 18(2), 2000, pp. 363-370